Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Treatment Clinical Trials for Uterine Sarcoma

Review the uterine sarcoma treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-5 of 5

Tailoring Therapy in Post-surgical Patients with Low-risk Endometrial Cancer
Status: Active
Location: 73 locations
Letrozole in Uterine Leiomyosarcoma
Status: Active
Location: 8 locations
Short Course Vaginal Cuff Brachytherapy in Treating Patients with Stage I-IIIA Endometrial Cancer
Status: Active
Location: 3 locations
Cytoreductive Surgery with Gemcitabine Followed by Dacarbazine for the Treatment of Locally Recurrent Uterine Leiomyosarcoma
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland